The Drug Controller General of India (DCGI), India's drug regulator, approved the emergency use of CoviShield and Covaxin on January 3, following the recommendations of the Subject Expert Committee (SEC). The results of Covishield's Phase-3 trials have come, but Covaxin's Phase-3 trials are ongoing.
Coveshield is co-created by Oxford University and AstraZeneca. It is being built in India by the Serum Institute of India (SII) of Adar Poonawala, Pune. At the same time, covaxin is an indigenous vaccine, which Bharat Biotech has created in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). Its phase-3 trials are going on.
The way the drug regulator has given emergency approval to both these vaccines, questions are being raised. The biggest question is about Covaxine, whose trial data is not available, that is, no one knows how effective this vaccine is. Experts say transparency was not maintained in the emergency approval process. Let's understand what is the objection of the experts and what does the government have to say on that?
What is the basis of emergency approval?
Drug Controller General of India VG Somani had said that we will not approve any vaccine which will have little safety concern. Both these vaccines are 110% safe. Side effects such as mild fever, pain, and allergies are caused by the vaccine.
Similar claims are also made by the members of the National Taskforce on the Covid-19. He claims that approval given to Covaxin is different from Covishield. AIIMS-Delhi director Dr. Randeep Guleria said that covaxin will be used as a back-up.
According to Dr. Guleria, till the final data of Bharat Biotech comes, the Covishield will be installed. Those who will apply Covaxin will take their consent. Will be monitored. It will be like clinical trials. When the final data of Covaxin arrives, it will also be allowed as Covishield.
Dr. Balaram Bhargava, Head of ICMR, says that we have done a lot of work at NIV, Pune for Covaxin's affixation data. Bronchoscopy was performed on monkeys for 14 days. The symptoms were seen every day and the effect of the vaccine was seen.
He says that Phase-1 trials of Covaxin consisted of 375 volunteers and Phase-2 consisted of 380 volunteers. Neither phase showed any serious side-effects. So far 23 thousand volunteers have been given the first dose under Phase-3 trials. But there are no concerns related to safety.
According to Dr. Bhargava, the entire virus has been targeted through covaxin. Other vaccines target the spike protein of the virus. In such a situation, the ability of covaxin against new strains has been important in its approval. This strain has now arrived in 34 countries. Because of this, it is extremely important to stop it.
What kind of questions are being raised on the vaccine approval process?
There are four main objections to the decision of India's Drug Regulator, DCGI -
1. Reliability: According to Dr. Anant Bhan, former president of the International Association of Bio-Ethics, only China and Russia have approved the vaccine before the results of Phase-3 trials. India has done the same. This puts the reliability of the regulatory process at bay.
2. Rule: Malina Isola of All India Drug Action Network says that under which rule the vaccine has been approved, it has not been given any information. The conditions related to the vaccine are also not mentioned.
3. Transparency: Epidemiologist Giridhar Babu says that if the use of covaxin will still be similar to clinical trials, what will be the process of getting consent? Have not answered any such questions.
4. Security data: Dr. Amar Jessani, editor of the Indian Journal of Medical Ethics, said the SEC has not presented any data on the issue of approving covaxine. How to know if this vaccine is completely safe and effective?
What is the main concern of experts?
Dr. Gagandeep Kang, one of the top vaccine scientists in the country, says that the regulatory process has led to confusion. If emergency approval has been given to covaxin, how will it be used in clinical trial mode? This has never happened before, how will it happen now? It would have known the impact and then giving emergency approval, there would be no problem.
They also say that the SII trials of Coveshield are being called Phase-2/3 trials. But it has everything that happens in phase-2 trials worldwide. That is, safety and immunogenicity are being seen in it, its effect is not being analyzed. If someone has asked how our approval differs from China and Russia, I have no answer.
What is the government's argument on the objections of experts?
Dr. Guleria states that there is no anti-viral drug available against coronavirus. As such, covaxin has been approved in the same way as remdesivir and hydroxychloroquine have been given limited approval.
He says cases have increased rapidly in Britain, the United States, and Europe. If we also have a fast case, then we also have to use covaxin as a back-up. It can be an effective weapon in preventing the spread of corona.
If there is no data regarding the effect of covaxin, Dr. Guleria says that at present, only the SII vaccine will be used more. When interim data from Covaxin's Phase-3 trials are revealed, it too will get approval like Covishield.
He says that caution will be maintained regarding the use of covaxin. It is not permitted to market the vaccine. It will be installed in trial mode only. That means its database will be maintained. Those who are vaccinated will have side-effects monitoring.
Rajasthan: 'If you do not leave the temple in 10 days, you will cut off your head', threatens the priest in Bharatpur, Kanhaiya will be the result
In Rajasthan, the process of getting threats of beheading the people of Hindu society is not stopping. The latest case has come to light from the Bharatpur district. The priest of the temple built at
Monsoon on track: Monsoon picks up pace, will cover Maharashtra in two days, will get relief from scorching heat soon
In many states of the country, the situation is worse than the heat, the hot air from above is troubling the people a lot. But now there is a relief from this scorching heat. The Meteorological
Not only the border, but China is also a big challenge in front of India on the trade front.
In the year 2020, after the skirmish of the Indian Army with the Chinese forces in the Galvan Valley of Ladakh, on 9 December, once again there was a serious confrontation between the soldiers of
PM Modi: 'New developed cities will become a new identity of India in the 21st century', PM Modi said in the webinar
Prime Minister Modi addressed the webinar organized on 'Urban Planning, Development and Sanitation' through video conferencing. During this, PM Modi said that both urban planning and urban governance
Rahul Gandhi's target, said- Central government destructive vaccine strategies will ensure the third wave
New Delhi: Congress leader Rahul Gandhi has again targeted the Modi government concerning vaccination. He said that the disastrous vaccine strategy of the Modi government will ensure the third wave.
What steps is India taking for trade with Russia amid the Ukraine crisis?
During the Ukraine-Russia war, the Government of India has constituted a group of ministries under the leadership of the Ministry of Finance. This group is working to solve the challenges coming in a
Redmi's best 5G phone is being booked on Amazon, know the deal price and features
Redmi Note 11 Pro + 5G on Amazon: If you want to get a strong phone before Holi, then the new launch phone Redmi Note 11 Pro + 5G is available on Amazon. The price of this phone is in the range of 20
The deadline for opening the Shambhu border is over: Farmers will march to Delhi, and tractors march across the country on 15 August.
The deadline for the High Court's order to open the Shambhu border of Punjab-Haryana is ending today. So far, no initiative has been taken by the government to open the border. The Haryana government
Donald Trump Shooting: America is a 'safe democracy'... this illusion is broken, former diplomat said after the attack on Donald Trump
Former diplomat Jitendranath Mishra, who was the Indian ambassador to Portugal and Laos, on Sunday said that the assassination attempt on former US President Donald Trump has shattered the illusion of
Russia-Ukraine War Updates: Russia bombed many cities of Ukraine, five were killed, 13 were injured in shelling in Kharkiv city
There has been a case of the bombing of Ukrainian cities by Russia. Officials say Russian shelling and airstrikes have targeted multiple targets across Ukraine. Five people were killed and 13 injured
